Core Laboratories Gross Profit vs. Revenue
| CLB Stock | USD 20.27 0.71 3.63% |
Gross Profit | First Reported 1995-03-31 | Previous Quarter 23.9 M | Current Value 23.9 M | Quarterly Volatility 27 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.2 | 0.1845 |
|
| |||||
| Operating Profit Margin | 0.14 | 0.1072 |
|
|
For Core Laboratories profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Core Laboratories to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Core Laboratories NV utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Core Laboratories's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Core Laboratories NV over time as well as its relative position and ranking within its peers.
Core |
Core Laboratories' Revenue Breakdown by Earning Segment
Check out Trending Equities.
Is Oil & Gas Equipment & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.316 | Dividend Share 0.04 | Earnings Share 0.54 | Revenue Per Share 11.158 | Quarterly Revenue Growth 0.072 |
The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Core Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Core Laboratories Revenue vs. Gross Profit Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Core Laboratories's current stock value. Our valuation model uses many indicators to compare Core Laboratories value to that of its competitors to determine the firm's financial worth. Core Laboratories NV is rated below average in gross profit category among its peers. It is rated below average in revenue category among its peers totaling about 5.31 of Revenue per Gross Profit. At present, Core Laboratories' Gross Profit is projected to decrease significantly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Core Laboratories' earnings, one of the primary drivers of an investment's value.Core Revenue vs. Gross Profit
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Core Laboratories |
| = | 96.08 M |
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Core Laboratories |
| = | 509.79 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Core Revenue vs Competition
Core Laboratories NV is rated below average in revenue category among its peers. Market size based on revenue of Energy industry is currently estimated at about 35.28 Billion. Core Laboratories claims roughly 509.79 Million in revenue contributing just under 2% to equities under Energy industry.
Core Laboratories Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Core Laboratories, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Core Laboratories will eventually generate negative long term returns. The profitability progress is the general direction of Core Laboratories' change in net profit over the period of time. It can combine multiple indicators of Core Laboratories, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -5 M | -5.2 M | |
| Operating Income | 54.6 M | 51.9 M | |
| Income Before Tax | 41.2 M | 39.1 M | |
| Total Other Income Expense Net | -13.4 M | -12.8 M | |
| Net Income | 37 M | 35.2 M | |
| Income Tax Expense | 4.2 M | 4 M | |
| Net Income Applicable To Common Shares | 22.4 M | 21.3 M | |
| Net Income From Continuing Ops | 37 M | 35.2 M | |
| Non Operating Income Net Other | -1.2 M | -1.2 M | |
| Interest Income | 10.4 M | 9.8 M | |
| Net Interest Income | -13.4 M | -14.1 M | |
| Change To Netincome | 11.4 M | 9.8 M | |
| Net Income Per Share | 0.79 | 1.25 | |
| Income Quality | 0.67 | 0.93 | |
| Net Income Per E B T | 0.89 | 0.54 |
Core Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Core Laboratories. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Core Laboratories position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Core Laboratories' important profitability drivers and their relationship over time.
Use Core Laboratories in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Core Laboratories position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Core Laboratories will appreciate offsetting losses from the drop in the long position's value.Core Laboratories Pair Trading
Core Laboratories NV Pair Trading Analysis
The ability to find closely correlated positions to Core Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Core Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Core Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Core Laboratories NV to buy it.
The correlation of Core Laboratories is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Core Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Core Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Core Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Core Laboratories position
In addition to having Core Laboratories in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Printing and Publishing Thematic Idea Now
Printing and Publishing
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Printing and Publishing theme has 21 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Printing and Publishing Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
To fully project Core Laboratories' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Core Laboratories at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Core Laboratories' income statement, its balance sheet, and the statement of cash flows.